Effect of human plasma on the reactivation of sarin-inhibited human erythrocyte acetylcholinesterase

Archives of Toxicology

Volumn 74, Issue 1, 2000, Pages 21-26

  Worek, F ^a,b   Eyer, P ^b   Kiderlen, D ^b   Thiermann, H ^a   Szinicz, L ^a  

^a Sanitatsakademie der Bundeswehr   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acetylcholinesterase; Human; Organophosphate; Oximes; Reactivation

Indexed keywords

ACETYLCHOLINESTERASE; OBIDOXIME; OXIME DERIVATIVE; PRALIDOXIME; SARIN;

ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; PLASMA; PRIORITY JOURNAL;

EID: 0034077724     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050647     Document Type: Article

References (35)

1. Aldridge WN, Reiner E (1972) Enzyme inhibitors as substrates - interactions of esterases with esters of organophosphorus and carbamic acids. North-Holland Publishing Company, Amsterdam London
2. Becker G, Kawan A, Szinicz L (1997) Direct reaction of oximes with sarin, soman, or tabun in vitro. Arch Toxicol 71: 714-718
3. Bismuth C, Inns RH, Marrs TC (1992) Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. In: Ballantyne B, Marrs TC (eds) Clinical and experimental toxicology of organophosphates and carbamates, Butterworth and Heinemann, Oxford, pp 555-577
4. Clement JG, Bailey DG, Madill HD, Tran LT, Spence JD (1995) The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine. Biopharm Drug Dispos 16: 415-425
5. de Jong LPA, Ceulen DI (1978) Anticholinesterase activity and rate of decomposition of some phosphylated oximes. Biochem Pharmacol 27: 857-863
6. de Jong LPA, Wolring GZ (1978) Effect of 1-(ar)-alkyl-hydroxy-iminomethyl-pyridinium salts on reactivation and aging of acetylcholinesterase inhibited by ethyldimethylphosphoramidocyanidate (tabun). Biochem Pharmacol 27: 2229-2235
7. Erdmann WD, Bosse I, Franke P (1965) Zur Resorption und Ausscheidung von Toxogonin nach intramuskulärer Injektion am Menschen. Dtsch Med Wochenschr 90: 1436-1438
8. Eyer P (1996) Optimal oxime dosage regimen, a pharmacokinetic approach. In: Szinicz L, Eyer P, Klimmek R (eds) Role of oximes in the treatment of anticholinesterase agent poisoning, Spektrum Akademischer Verlag, Heidelberg, pp 33-51
9. Eyer P, Hagedorn I, Klimmek R, Lippstreu P, Löffler M, Oldiges H, Spöhrer U, Steidl I, Szinicz L, Worek F (1992) HLÖ 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases. Arch Toxicol 66: 603-621
10. Green AL, Saville B (1956) The reaction of oximes with isopropyl methylphosphonofluoridate (sarin). J Chem Soc 3887-3892
11. Hackley BE, Steinberg GM, Lamb JC (1959) Formation of potent inhibitors of AChE by reaction of pyridinaldoximes with isopropyl methylphosphonofluoridate (GB). Arch Biochem Biophys 80: 211-214
12. Hahn HL, Henschler D (1969) Zur Reaktivierbarkeit phosphorylierter Cholinesterasen durch Obidoximchlorid (Toxogonin) in vivo. Arch Toxikol 24: 147-163
13. Harvey B, Sellers DJ, Watts P (1984) The reactivation by oximes of phosphonylated acetylcholinesterase: the possible erroneous interpretation of reactivating potency. Biochem Pharmacol 33: 3499-3501
14. Harvey B, Scott RP, Sellers DJ, Watts P (1986) In vitro studies on the reactivation by oximes of phosphylated acetylcholinesterase - I. Biochem Pharmacol 35: 737-744
15. Heilbronn E (1963) In vitro reactivation and "ageing" of tabun-inhibited blood cholinesterase. Biochem Pharmacol 12: 25-36
16. Jovanovic D (1989) Pharmacokinetics of pralidoxime chloride - a comparative study in healthy volunteers and in organophosphorus poisoning. Arch Toxicol 63: 416-418
17. Kuo CL, LaDu BN (1995) Comparison of purified human and rabbit serum paraoxonases. Drug Metab Dispos 23: 935-944
18. Kiderlen D, Worek F, Klimmek R, Eyer P (2000) The phosphoryl oxime destroying activity of human plasma. Arch Toxicol, in press
19. Lamb JC, Steinberg GM, Hackley BE (1964) Isopropyl methylphosphonylated bisquaternary oximes, powerful inhibitors of cholinesterase. Biochim Biophys Acta 89: 174-176
20. Leader H, Vincze A, Manisterski B, Rothschild N, Dosoretz C, Ashani Y (1999) Characterization of O,O-diethylphosphoryl oximes as inhibitors of cholinesterases and substrates of phosphotriesterases. Biochem Pharmacol 58: 503-515
21. Luo C, Saxena A, Smith M, Garcia G, Radic Z, Taylor P, Doctor BP (1999) Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium. Biochemistry 38: 9937-9947
22. Mast U (1997) Reaktivierung der Erythrozyten-Acetylcholinesterase durch Oxime. Thesis, München
23. Nagao M, Takatori T, Matsuda Y, Nakajima M, Iwase H, Iwadate K (1997) Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol Appl Pharmacol 144: 198-203
24. Nenner M (1974) Phosphonylierte Aldoxime. Hemmwirkung auf Acetylcholinesterase und hydrolytischer Abbau. Biochem Pharmacol 23: 1255-1262
25. Portmann R, Niederhauser A, Hofmann W, Frey A (1991) Synthesis of 4-{{[(isopropyloxy)methylphosphoryloxy]imino}methyl}-1-methylpyridinium iodide and its characterisation. Helv Chim Acta 74: 331-335
26. Scaife JF (1959) Oxime reactivation studies of inhibited true and pseudo cholinesterase. Can J Biochem Physiol 37: 1301-1311
27. Schoene K (1973) Phosphonyloxime aus Soman: Bildung und Reaktion mit Acetylcholinesterase in vitro. Biochem Pharmacol 22: 2997-3003
28. Sidell FR (1992) Clinical considerations in nerve agent intoxication. In: Somani SM (ed) Chemical warfare agents. Academic Press, San Diego, pp 155-194
29. Thiermann H, Mast U, Klimmek R, Eyer P, Hibler A, Pfab R, Felgenhauer N, Zilker T (1997) Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum Exp Toxicol 16: 473-480
30. Wilson IB, Ginsburg S (1955) A powerful reactivator of alkyl-phosphate-inhibited acetylcholinesterase. Biochim Biophys Acta 18: 168-170
31. Worek F, Bäcker M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P (1997) Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 16: 466-472
32. Worek F, Eyer P, Szinicz L (1998a) Inhibition, reactivation and aging kinetics of cyclohexylmethylphosphonofluoridate-inhibited human cholinesterases. Arch Toxicol 72: 580-587
33. Worek F, Widmann R, Knopff O, Szinicz L (1998b) Reactivating potency of obidoxime, pralidoxime, HI 6 and HLÖ 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 72: 237-243
34. Worek F, Diepold C, Eyer P (1999a) Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics. Arch Toxicol 73: 7-14
35. Worek F, Mast U, Kiderlen D, Diepold C, Eyer P (1999b) Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 288: 73-90